Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
10,57 USD | +4,40% | +9,19% | +72,71% |
Attività
Numero di dipendenti: 122
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
DNA Medicines
100,0
%
| 10 | 100,0 % | 1 | 100,0 % | -91,89% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 10 | 100,0 % | 1 | 100,0 % | -91,89% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 25/03/19 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 01/06/02 |
Chief Tech/Sci/R&D Officer | - | 01/02/07 | |
Jeffrey Skolnik
CTO | Chief Tech/Sci/R&D Officer | - | 12/10/16 |
Michael Sumner
CTO | Chief Tech/Sci/R&D Officer | 59 | 27/06/22 |
Laurent Humeau
CTO | Chief Tech/Sci/R&D Officer | 57 | 18/02/14 |
Thomas Hong
IRC | Investor Relations Contact | - | - |
Cheryl Elder
LAW | General Counsel | - | - |
Shawn D. Bridy
PRN | Corporate Officer/Principal | - | 24/05/18 |
Maggie Campbell
AUD | Comptroller/Controller/Auditor | - | 01/03/06 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 01/12/03 |
Lota Zoth
BRD | Director/Board Member | 64 | 01/01/18 |
Jay Shepard
BRD | Director/Board Member | 66 | 15/01/20 |
Wendy Yarno
BRD | Director/Board Member | 68 | 06/12/17 |
David Weiner
FOU | Founder | 67 | 29/06/83 |
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 25/03/19 |
Roger Dansey
BRD | Director/Board Member | 68 | 13/05/21 |
Ann Miller
BRD | Director/Board Member | 66 | 25/03/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 1 091 | 0 | 1 082 ( 99,18 %) | 98,51 % |
Azione B | 1 | 25 329 333 | 24 953 826 ( 98,52 %) | 0 |
Coordinate società
Inovio Pharmaceuticals, Inc.
660 West Germantown Pike Suite 110
19462-1111, Plymouth Meeting
+267 440 4200
http://www.inovio.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+72,71% | 274 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione INO
- Società Inovio Pharmaceuticals, Inc.